Safe­ty risk push­es FDA to cut off J&J's Covid-19 vac­cine with some lim­it­ed ex­cep­tions

Cas­es of a syn­drome with rare and life-threat­en­ing blood clots in com­bi­na­tion with low lev­els of blood platelets war­rant lim­it­ing the au­tho­rized use of J&J’s Covid-19 vac­cine, the FDA said Thurs­day.

The agency said it con­firmed a to­tal of 60 cas­es of what’s known as throm­bo­sis with throm­bo­cy­tope­nia syn­drome, or TTS, in­clud­ing 9 deaths re­port­ed to the agency’s Vac­cine Ad­verse Event Re­port­ing Sys­tem, out of about 8 mil­lion dos­es of the one-dose shot ad­min­is­tered.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER